Sandor Victor 4
4 · Prelude Therapeutics Inc · Filed Jun 18, 2024
Insider Transaction Report
Form 4
Sandor Victor
Director
Transactions
- Award
Director Stock Option (Right to Buy)
2024-06-14+23,500→ 23,500 totalExercise: $3.90Exp: 2034-06-13→ Common Stock (23,500 underlying)
Footnotes (1)
- [F1]The option award will fully vest upon the earlier of (a) the Issuer's next annual stockholder meeting, or (b) the one-year anniversary of the grant date, subject to the Reporting Person's provision of service to the Issuer on each vesting date.